Ralinepag

N/A

Report date: 2026/03/29 20:00:13
NME

Base Information

Drug NameRalinepag
Drug Alias Name雷利帕格Ralinepagum雷立奈帕CQY-12ZJN6EAPD-811
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstanoid IP receptor agonists
TargetsProstanoid IP receptor
Therapy Area/IndicationsConnective Tissue DiseasesHypertensionVascular Diseases +[10
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[37
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesArena Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesUnited Therapeutics Corp
Active IndicationsConnective Tissue DiseasesHypertensionVascular Diseases +[8
Inactive IndicationsCardiovascular DiseasesRespiratory Tract Diseases

Other Information

ATC CodeN/A
Related LinksKEGG